Reproductive endocrinology: Metformin or thiazolidinedione therapy in PCOS?

Nature Reviews Endocrinology

Volumn 7, Issue 3, 2011, Pages 128-129

  Grover, Anjali ^a   Yialamas, Maria A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PIOGLITAZONE; PRASTERONE SULFATE; ROSIGLITAZONE; TESTOSTERONE; TRIACYLGLYCEROL; 2,4 THIAZOLIDINEDIONE DERIVATIVE;

ACNE; ALOPECIA; ANDROGEN BLOOD LEVEL; ANDROGEN SYNTHESIS; ANDROSTENEDIONE BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HIRSUTISM; HUMAN; HYPERANDROGENISM; IMPAIRED GLUCOSE TOLERANCE; INFERTILITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LACTIC ACIDOSIS; LIVER TOXICITY; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OLIGOMENORRHEA; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; OVULATION; PATHOGENESIS; POPULATION; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; FEMALE; NOTE;

FEMALE; HUMANS; METFORMIN; POLYCYSTIC OVARY SYNDROME; THIAZOLIDINEDIONES;

EID: 79952185443     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.16     Document Type: Short Survey

References (10)

1. Apridonidze, T., Essah, P. A., Iuorno, M. J. & Nestler, J. E. Prevalence and Characteristics of the Metabolic syndrome in women with Polycystic Ovary syndrome. J. Clin. Endocrinol. Metab. 90, 1929-1935 (2005).
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19-25 (2004).
3. Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K. & Imperial, J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141-146 (1999).
4. Li, X. et al. Metformin versus thiazolidinediones for treatment of clinical, hormonal, and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clin. Endocrinol. (Oxf.) doi:10.1111/j.1365-2265.2010.03917.x.
5. Ehrmann, D. Polycystic ovary syndrome. N. Engl. J. Med. 352, 1223-1236 (2005).
6. Lord, J. M., Flight, I. H. & Norman, R. J. Metformin in polycystic ovary syndrome; systematic review and meta-analysis. BMJ 327, 951-953 (2003).
7. Nestler, J. E., Jakubowicz, D. J., Evans, W. S. & Pasquali, R. Effects of metformin on spontaneous and clomiphene insuced ovulation in the polycystic ovary syndrome. N. Engl. J. Med. 338, 1876-1880 (1998).
8. Legro, R. S. et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 356, 551-566 (2007).
9. Azziz, R. et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 86, 1626-1632 (2001).
10. Ortega-González, C. et al. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90, 1360-1365 (2005).